Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer. | Cancers Head Neck | 2020 | 32944296 | PubTator, text mining | PubMed |
| Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck. | Clin Cancer Res | 2020 | 32943457 | PubTator, text mining | PubMed |
| The self-fulfilling prophecy of pulmonary fibrosis: a selective inspection of pathological signalling loops. | Eur Respir J | 2020 | 32943406 | PubTator, text mining | PubMed |
| Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts. | Theranostics | 2020 | 32929378 | PubTator, text mining | PubMed |
| mTOR Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer. | Front Oncol | 2020 | 32923403 | PubTator, text mining | PubMed |
| Torin2 inhibits the EGFR-TKI resistant Non-Small Lung Cancer cell proliferation through negative feedback regulation of Akt/mTOR signaling. | J Cancer | 2020 | 32913468 | PubTator, text mining | PubMed |
| Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer. | Br J Cancer | 2020 | 32913286 | PubTator, text mining | PubMed |
| Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer. | Cancers (Basel) | 2020 | 32911743 | PubTator, text mining | PubMed |
| Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer. | Cancers (Basel) | 2020 | 32911610 | PubTator, text mining | PubMed |
| The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia. | Nat Commun | 2020 | 32908143 | PubTator, text mining | PubMed |
| mTOR-Dependent Role of Sestrin2 in Regulating Tumor Progression of Human Endometrial Cancer. | Cancers (Basel) | 2020 | 32899752 | PubTator, text mining | PubMed |
| In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy. | Cancers (Basel) | 2020 | 32899149 | PubTator, text mining | PubMed |
| Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer. | Diagnostics (Basel) | 2020 | 32878288 | PubTator, text mining | PubMed |
| Searching for the real function of mTOR signaling in the regulation of PD-L1 expression. | Transl Oncol | 2020 | 32854033 | PubTator, text mining | PubMed |
| mTORC1 Is Not Principally Involved in the Induction of Human Endotoxin Tolerance. | Front Immunol | 2020 | 32849516 | PubTator, text mining | PubMed |
| HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers. | Oncogene | 2020 | 32848210 | PubTator, text mining | PubMed |
| Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies. | Int J Mol Sci | 2020 | 32842547 | PubTator, text mining | PubMed |
| Exhausted CD4+ T Cells during Malaria Exhibit Reduced mTORc1 Activity Correlated with Loss of T-bet Expression. | J Immunol | 2020 | 32817333 | PubTator, text mining | PubMed |
| Complement modulation reverses pathology in Y402H-retinal pigment epithelium cell model of age-related macular degeneration by restoring lysosomal function. | Stem Cells Transl Med | 2020 | 32815311 | PubTator, text mining | PubMed |
| Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling. | Med Sci Monit | 2020 | 32804918 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=42